⌘K
Loading ticker…
As of 2026-08-24, Hinge Health, Inc. (HNGE) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47.8 (Neutral). Sector: Technology, ranked 2 of 11. Average daily range 5.7%, relative volume 1.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
HNGE is in a stage 2 uptrend, week 7. Currently in a 10-day base; basing ADR 4.4% (broad 5.3%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 10.4% / 64.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
HNGE is held by 8 ETFs as of May 2026. Top owner: SCHA at 0.02% weight, $4M notional. Top 3 carry $8M.
Held by 25 ETFs · $111M across latest filings · largest weight 1.77% (HEAL).
Top 8 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| LFSC | 0.94% | $989K | −0.12 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $506K | — |
| HEAL | 1.77% | $444K |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| +1.17 pp |
| ACSG | 0.45% | $76K | +0.11 pp |
| WSML | 0.01% | $56K | — |
| GTPE | 0.01% | $2K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HNGE Jan avg: -24.87% median: -24.87% win: 0% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Feb avg: 22.52% median: 22.52% win: 100% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Mar avg: -9.82% median: -9.82% win: 0% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Apr avg: 15.66% median: 15.66% win: 100% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE May avg: 14.72% median: 14.72% win: 100% σ: 16.00% n: 2 2025-05-23 → 2026-07-31 | HNGE Jun avg: 40.45% median: 40.45% win: 100% σ: 10.20% n: 2 2025-05-23 → 2026-07-31 | HNGE Jul avg: -11.56% median: -11.56% win: 0% σ: 2.23% n: 2 2025-05-23 → 2026-07-31 | HNGE Aug avg: 24.76% median: 24.76% win: 100% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 (current) | HNGE Sep avg: -12.48% median: -12.48% win: 0% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Oct avg: 1.39% median: 1.39% win: 100% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Nov avg: -1.71% median: -1.71% win: 0% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 | HNGE Dec avg: -5.03% median: -5.03% win: 0% σ: 0.00% n: 1 2025-05-23 → 2026-07-31 |